VA SB592 | 2024 | Regular Session
Note: Carry Foward to future SB592
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 10 2024 - 25% progression, died in committee
Action: 2024-02-08 - Continued to 2025 in Education and Health (15-Y 0-N)
Pending: Senate Education and Health Committee
Text: Latest bill text (Prefiled) [HTML]
Status: Introduced on January 10 2024 - 25% progression, died in committee
Action: 2024-02-08 - Continued to 2025 in Education and Health (15-Y 0-N)
Pending: Senate Education and Health Committee
Text: Latest bill text (Prefiled) [HTML]
Summary
Department of Medical Assistance Services; Preferred Drug List/Common Core Formulary; approval of a nonpreferred drug. Directs the Department of Medical Assistance Services to eliminate the requirement that a patient try and fail a drug from the Preferred Drug List/Common Core Formulary in the six months immediately prior to approval of a nonpreferred drug when such patient has previously tried the drug from the Preferred Drug List/Common Core Formulary and experienced harmful side effects.
Title
Preferred Drug List/Common Core Formulary; approval of a nonpreferred drug.
Sponsors
Roll Calls
2024-02-08 - Senate - Senate: Continued to 2025 in Education and Health (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-02-08 | Senate | Continued to 2025 in Education and Health (15-Y 0-N) |
2024-02-05 | Senate | Assigned Education and Health Sub: Health |
2024-01-10 | Senate | Referred to Committee on Education and Health |
2024-01-10 | Senate | Prefiled and ordered printed; offered 01/10/24 24103030D |
Same As/Similar To
SB592 (Carry Over) 2024-02-08 - Continued to 2025 in Education and Health (15-Y 0-N)